Five medical devices stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).
Winner Medical Group (WWIN) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
CryoLife, Inc. (CRY) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. CryoLife preserves and distributes human tissues in addition to developing, manufacturing, and commercializing medical devices for cardiac and vascular transplant applications. For more information, get Portfolio Grader’s complete analysis of CRY stock.
This week, ZELTIQ Aesthetics, Inc.’s (ZLTQ) ratings are up from a B last week to an A. Zeltiq Aesthetics provides medical services. For more information, get Portfolio Grader’s complete analysis of ZLTQ stock.
Neogen Corporation (NEOG) earns a B this week, jumping up from last week’s grade of C. Neogen develops and markets products and services dedicated to food and animal safety. For more information, get Portfolio Grader’s complete analysis of NEOG stock.
Merit Medical Systems, Inc. (MMSI) gets a higher grade this week, advancing from a C last week to a B. Merit Medical Systems is engaged in the development, manufacture, and marketing of disposable medical products that are used primarily in diagnostic and interventional cardiology and radiology procedures. For more information, get Portfolio Grader’s complete analysis of MMSI stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
